The Role of SARS-CoV-2 Nucleocapsid Protein in Antiviral Immunity and Vaccine Development

Haiyun Yu,Fei Guan,Heather G. Miller,Jiahui Lei,Chaohong Liu
DOI: https://doi.org/10.1080/22221751.2022.2164219
2023-01-01
Emerging Microbes & Infections
Abstract:The coronavirus disease 2019 (COVID-19) has caused enormous health risks and global economic disruption. This disease is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 nucleocapsid protein is a structural protein involved in viral replication and assembly. There is accumulating evidence indicating that the nucleocapsid protein is multi-functional, playing a key role in the pathogenesis of COVID-19 and antiviral immunity against SARS-CoV-2. Here, we summarize its potential application in the prevention of COVID-19, which is based on its role in inflammation, cell death, antiviral innate immunity, and antiviral adaptive immunity.
What problem does this paper attempt to address?